 |
市場調查報告書
商品編碼
2054231
CRISPR和Cas基因市場規模、佔有率和成長分析：按產品類型、Cas類型、應用、最終用戶、交付方式、工作流程和地區分類－2026-2033年產業預測CRISPR And Cas Genes Market Size, Share, and Growth Analysis, By Product Type, By Cas Type, By Application, By End User, By Delivery Method, By Workflow, By Region - Industry Forecast 2026-2033 |
||||||
2024 年全球 CRISPR 和 Cas 基因市場價值為 45 億美元，預計到 2025 年將成長至 52.4 億美元，到 2033 年將成長至 177.9 億美元，在預測期（2026-2033 年）內複合年成長率為 16.5%。
CRISPR和Cas基因市場的主要驅動力是基因編輯技術的進步，這些技術在基因組修飾方面提供了前所未有的精準性和擴充性。該市場涵蓋了研究、藥物開發和農業創新所需的關鍵工具、試劑、服務和治療平台，有助於治療遺傳疾病、提高作物產量和加快診斷速度。臨床和監管檢驗對市場成長有顯著影響，成功的臨床試驗能帶來更多投資和合作，並加速商業化進程。此外，人工智慧（AI）透過改進設計和開發流程，正在加速市場發展。人工智慧應用，例如引導RNA最佳化和用於識別脫靶風險的預測模型，能夠簡化實驗工作流程。將人工智慧融入研發，透過加速發現週期和加強監管合規及生產決策的證據基礎，正在創造新的商機。
全球 CRISPR 和 Cas 基因市場促進因素
全球CRISPR和Cas基因市場的主要促進因素之一是對基因工程和生物技術研究進展日益成長的需求。 CRISPR技術能夠實現精準的基因編輯，為農業、醫學和工業生物技術領域的創新開闢了新的途徑。人們對個人化醫療的日益關注，以及對有效基因療法治療各種疾病的需求，正在推動該領域的投資和舉措。此外，遺傳疾病的日益普遍以及對永續農業實踐的重視，正在加速CRISPR解決方案的普及應用，從而推動市場成長。
全球 CRISPR 和 Cas 基因市場的限制因素
全球CRISPR和Cas基因市場的主要限制因素之一是圍繞基因編輯技術的倫理和監管問題。隨著CRISPR技術的進步，其在各個領域的潛在應用引發了關於人類、動物和植物性因改造的重大倫理議題。這些倫理困境可能導致嚴格的監管和輿論反彈，從而阻礙研究和商業化進程。此外，不同地區監管機構複雜的核准流程也會減緩創新和技術應用的速度，進而限制市場成長。因此，相關人員需要克服這些挑戰，才能有效釋放CRISPR技術的潛力。
CRISPR和Cas基因市場的全球趨勢
全球CRISPR和Cas基因市場正呈現出顯著的治療產品線拓展趨勢，創新者正將目光從傳統的單基因疾病轉向更廣泛的疾病適應症。這一轉變涵蓋了複雜的慢性疾病和感染疾病，生物技術公司與學術機構之間日益密切的合作正在加速轉化研究。與監管機構的早期合作以及標準化檢測平台的建立，進一步簡化了研發流程，推動了創新基因編輯策略的出現。這一趨勢正在促進產品組合的多元化，吸引大量投資進入臨床項目，最終拓展商業性機遇，並使更多患者群體受益。
目錄
介紹
- 調查目的
- 市場定義和範圍
調查方法
- 研究過程
- 二級資料和一級資料的方法
- 市場規模估算方法
執行摘要
- 全球市場展望
- 市場主要亮點
- 細分市場概覽
- 競爭環境概述
市場動態及展望
- 總體經濟指標
- 促進者和機會
- 抑制因素和挑戰
- 供給面趨勢
- 需求面趨勢
- 波特的分析和影響
關鍵市場分析
- 關鍵成功因素
- 影響市場的因素
- 主要投資機會
- 生態系測繪
- 2025年市場魅力指數
- PESTLE分析
- 監理情勢
- 價值鏈分析
- 案例研究
- 技術評估
- 客戶和採購標準分析
- 管道分析
- 疾病流行病學
全球 CRISPR 和 Cas 基因市場規模：按產品類型分類
- CRISPR試劑盒和試劑
- Cas酶
- 引導RNA
- CRISPR 文庫
- 配送系統
- 其他
全球 CRISPR 和 Cas 基因市場規模：按 Cas 類型分類
- Cas9
- Cas12
- Cas13
- 其他 Cas 變體
全球 CRISPR 和 Cas 基因市場規模：按應用領域分類
- 基因組編輯
- 細胞株工程
- 基因治療
- 藥物發現
- 診斷
- 農業生物技術
- 其他
全球 CRISPR 和 Cas 基因市場規模：按最終用戶分類
- 製藥和生物技術公司
- 學術研究機構
- 受託研究機構（CRO）
- 診斷檢查室
全球 CRISPR 和 Cas 基因市場規模：按遞送方式分類
- 病毒傳播
- 非病毒遞送
- 實體交付方式
全球 CRISPR 和 Cas 基因市場規模：按工作流程分類
- 體內基因組編輯
- 體外基因組編輯
- 體外應用
全球 CRISPR 和 Cas 基因市場規模：按地區分類
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
- 拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲國家
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家
競爭資訊
- 前五大公司對比
- 主要公司2025年的市場定位
- 主要市場公司採取的策略
- 近期市場趨勢
- 企業市場占有率分析，2025 年
- 主要公司的完整公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 銷售收入年比比較（2023-2025 年）
主要公司簡介
- CRISPR Therapeutics
- Editas Medicine
- Intellia Therapeutics
- Caribou Biosciences
- Beam Therapeutics
- Mammoth Biosciences
- Synthego
- Integrated DNA Technologies
- Thermo Fisher Scientific
- Merck KGaA
- Agilent Technologies
- GenScript Biotech
- Cellectis
- ToolGen
- Inscripta
- Horizon Discovery
- Danaher Corporation
- AstraZeneca
- Precision BioSciences
- eGenesis
結論與建議
Global Crispr And Cas Genes Market size was valued at USD 4.5 Billion in 2024 and is poised to grow from USD 5.24 Billion in 2025 to USD 17.79 Billion by 2033, growing at a CAGR of 16.5% during the forecast period (2026-2033).
The CRISPR and Cas genes market is primarily driven by advancements in gene editing technologies, offering unparalleled precision and scalability for genome modification. This market includes tools, reagents, services, and therapeutic platforms essential for research, drug development, and agricultural innovation, translating into treatments for genetic diseases, improved crop yields, and expedited diagnostics. Clinical and regulatory validation significantly influences growth, with successful trial outcomes fostering increased investments, collaborations, and faster commercialization. Additionally, artificial intelligence accelerates market development by enhancing design and development processes. AI applications, such as guide RNA optimization and predictive models that identify off-target risks, streamline experimental workflows. This integration of AI in research and development promotes faster discovery cycles and bolsters the evidence base for regulatory compliance and manufacturing decisions, fostering new revenue opportunities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Crispr And Cas Genes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Crispr And Cas Genes Market Segments Analysis
Global crispr and cas genes market is segmented by product type, cas type, application, end user, delivery method, workflow and region. Based on product type, the market is segmented into CRISPR Kits & Reagents, Cas Enzymes, Guide RNA, CRISPR Libraries, Delivery Systems and Others. Based on cas type, the market is segmented into Cas9, Cas12, Cas13 and Other Cas Variants. Based on application, the market is segmented into Genome Editing, Cell Line Engineering, Gene Therapy, Drug Discovery, Diagnostics, Agricultural Biotechnology and Others. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations (CROs) and Diagnostic Laboratories. Based on delivery method, the market is segmented into Viral Delivery, Non-Viral Delivery and Physical Delivery Methods. Based on workflow, the market is segmented into In Vivo Genome Editing, Ex Vivo Genome Editing and In Vitro Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Crispr And Cas Genes Market
One of the key market drivers for the global CRISPR and Cas genes market is the increasing demand for advancements in genetic engineering and biotechnology research. The ability of CRISPR technology to facilitate precise gene editing has opened new avenues for innovations in agriculture, medicine, and industrial biotechnology. This growing interest in personalized medicine, coupled with the need for effective genetic treatments for various diseases, is fueling investments and research initiatives in the field. Furthermore, the rising prevalence of genetic disorders and the push for sustainable agricultural practices are propelling the adoption of CRISPR-based solutions, thereby driving market growth.
Restraints in the Global Crispr And Cas Genes Market
One key market restraint for the global CRISPR and Cas genes market is the ethical and regulatory concerns surrounding genetic editing technologies. As CRISPR technology advances, its potential applications in various fields raise significant moral questions regarding genetic modification in humans, animals, and plants. These ethical dilemmas can lead to stringent regulations and public backlash, potentially hindering research and commercialization efforts. Additionally, the complexity of obtaining regulatory approval in different regions may slow down the pace of innovation and adoption, limiting market growth. Consequently, stakeholders must navigate these challenges to harness the full potential of CRISPR technologies effectively.
Market Trends of the Global Crispr And Cas Genes Market
The Global Crispr and Cas Genes market is experiencing a significant trend towards the expansion of therapeutic pipelines, as innovators shift their focus to a wider array of disease indications beyond traditional single-gene disorders. This shift includes complex chronic diseases and infectious conditions, with increased collaboration between biotech firms and academic institutions facilitating rapid translational research. The early engagement with regulatory bodies and the establishment of standardized assay platforms are further streamlining the development process, permitting innovative gene-editing strategies to emerge. This trend fosters portfolio diversification and attracts considerable investment into clinical programs, ultimately broadening commercial opportunities and reaching new patient demographics.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Value Chain Analysis
- Case Studies
- Technology Assessment
- Customer & Buying Criteria Analysis
- Pipeline Analysis
- Disease Epidemiology
Global CRISPR And Cas Genes Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- CRISPR Kits & Reagents
- Cas Enzymes
- Guide RNA
- CRISPR Libraries
- Delivery Systems
- Others
Global CRISPR And Cas Genes Market Size by Cas Type & CAGR (2026-2033)
- Market Overview
- Cas9
- Cas12
- Cas13
- Other Cas Variants
Global CRISPR And Cas Genes Market Size by Application & CAGR (2026-2033)
- Market Overview
- Genome Editing
- Cell Line Engineering
- Gene Therapy
- Drug Discovery
- Diagnostics
- Agricultural Biotechnology
- Others
Global CRISPR And Cas Genes Market Size by End User & CAGR (2026-2033)
- Market Overview
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
- Diagnostic Laboratories
Global CRISPR And Cas Genes Market Size by Delivery Method & CAGR (2026-2033)
- Market Overview
- Viral Delivery
- Non-Viral Delivery
- Physical Delivery Methods
Global CRISPR And Cas Genes Market Size by Workflow & CAGR (2026-2033)
- Market Overview
- In Vivo Genome Editing
- Ex Vivo Genome Editing
- In Vitro Applications
Global CRISPR And Cas Genes Market Size & CAGR (2026-2033)
- North America (Product Type, Cas Type, Application, End User, Delivery Method, Workflow)
- US
- Canada
- Europe (Product Type, Cas Type, Application, End User, Delivery Method, Workflow)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Cas Type, Application, End User, Delivery Method, Workflow)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Cas Type, Application, End User, Delivery Method, Workflow)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Cas Type, Application, End User, Delivery Method, Workflow)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- CRISPR Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Editas Medicine
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Intellia Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Caribou Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Beam Therapeutics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mammoth Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synthego
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Integrated DNA Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cellectis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ToolGen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Inscripta
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Horizon Discovery
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Precision BioSciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- eGenesis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
CRISPR和Cas基因市場：按Cas類型、遞送方法、技術、應用和最終用戶分類－2026-2032年全球市場預測
CRISPR和Cas基因編輯市場：按產品類型、應用、最終用戶和地區分類Cas9核酸酶市場：按類型、形式、遞送方式、應用、最終用戶和治療領域分類－2026-2032年全球預測
CRISPR和Cas基因市場－全球產業規模、佔有率、趨勢、機會及預測（按產品/服務、應用、最終用途、地區和競爭格局分類，2021-2031年）Cas12核酸酶市場按產品、技術、應用和最終用戶分類，全球預測，2026-2032年
全球 CRISPR 和 Cas 基因市場規模（按類型、應用、最終用戶、區域範圍和預測）
CRISPR 和 Cas 基因市場，按產品類型、按技術、按交付方式、按治療領域、按最終用戶、按國家和地區 - 2025 年至 2032 年全球行業分析、市場規模、市場佔有率和預測
CRISPR 和 Cas 基因市場規模、佔有率和趨勢分析報告：按產品/服務、應用、最終用途、地區和細分市場預測，2025-2030 年CRISPR Cas9全球市場:市場機會及臨床試驗預測(2029年)